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Microalbuminuria in children with urinary tract 
infection
Purpose: Microalbuminuria is defined as increased urinary albumin ex-
cretion (30-300 mg/day) or microalbumin/creatinine ratio (30-300 mg/
g) in a spot urine sample. Although microalbuminuria is a predictor of 
clinical nephropathy and cardiomyopathy, few studies have investigated 
microalbuminuria in children with urinary tract infection (UTI). 
Therefore, we compared the spot urine microalbumin/creatinine ratio 
in pediatric UTI patients with that of control subjects. 
Methods: We investigated the correlation between the ratio in children 
with UTI and age, height, weight, blood pressure, glomerular filtration 
rate (GFR), hematuria, vesicoureteral reflux, renal parenchymal defect, 
and renal scar, and its predictability for UTI complications. 
Results: We studied 66 patients (42 boys, 24 girls) and 52 healthy 
children (24 boys, 28 girls). The mean microalbumin/creatinine ratio 
in UTI patients was statistically significantly increased compared 
to the control group (340.04±321.36 mg/g vs. 225.68±154.61 mg/
g, P=0.0141). The mean value of spot urine microalbumin/creatinine 
ratio (384.70±342.22 mg/g vs. 264.92±158.13 mg/g, P=0.0341) in 
1-23 months age patient group showed statistically significant increase 
compared to control group. Microalbumin/creatinine ratio showed 
negative correlation to age (r=-0.29, P=0.0167), body surface area 
(BSA) (r=-0.29, P=0.0173) and GFR (r=-0.26, P=0.0343). The presence 
of hematuria (P=0.0169) was found to be correlated. 
Conclusion: The spot urine microalbumin/creatinine ratio in children 
with UTI was significantly greater than that in normal children, 
and it was positively correlated with GFR. This ratio is a potential 
prescreening and prognostic marker in UTI patients. Further studies are 
required to validate the predictability of microalbuminuria in pediatric 
UTI patients.
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Introduction
Microalbuminuria is defined as increased urinary albumin 
excretion, between 30 and 300 mg/day or between 30 and 300 
mg/g microalbumin/creatinine ratio in a spot urine sample
1-3). 
It is known as a predictor of clinical nephropathy in patients 
with diabetes mellitus, and a risk factor of cardiomyopathy and 
nephropathy in the general adult population
4). Few studies have 
investigated microalbuminuria in children and the validity of pre-
screening by measuring microalbuminin in spot urine samples 
to identify children with urinary tract infection (UTI)
5, 6). We 
therefore elected to compare the spot urine microalbumin/ 
creatinine ratios of pediatric patients with UTI (patient group) 
with that of healthy control subjects (control group). We assessed 
the correlation between spot urine microalbumin/creatinine ratio 
and age, height, weight, blood pressure, glomerular filtration rate 
(GFR), hematuria, vesicoureteral reflux (VUR), renal parenchymal 
defect and renal scar in children with UTI, and the predictability 
of microalbumin/creatinine ratios in spot urine samples for UTI 
complications.
Materials and methods
The age, height, weight, blood pressure, serum glucose, serum 
creatinine, spot urine creatinine and microalbumin in 66 (42 boys 
and 24 girls) pediatric patients with UTI admitted to the Konkuk 
University Hospital from July 2007 to September 2009, and 52 
(24 boys and 28 girls) healthy children were evaluated. The patient 
group had fever, pyuria and fulfilled the diagnostic criteria of UTI: 
the presence of more than 100,000 colonies of a single pathogen in 
urinary culture
7). Spot morning urine creatinine and microalbumin 
in UTI patients were evaluated when fever was subsided and 
follow-up urine culture was negative. Hematuria was defined 
5 or more RBCs per high-power field (HPF) in specimen or a 
positive reaction on the urine dipstick test
8). Persistent hematuria or 
glomerulonephropathy were excluded in this study.  VUR or renal 
parenchymal defects were detected by voiding cystoureterography 
(VCUG) and 
99mTc-dimercaptosuccinicacid (DMSA) scan. VUR 
was graded on a scale of I to V according to the classification defined 
by the international reflux grading system
9). Age, sex, height z-score, 
weight z-score were matched between the patient and control 
groups. Height z-score, weight z-score were determined using the 
LMS method. GFR, adjusted for body surface area was calculated 
using the Schwartz formula [GFR (mL/min/1.73m
2)=κ×height 
(cm)/serum creatinine (mg/dL), κ=0.33 for low birth weight infants, 
0.45 for term appropriate gestation age infants, 0.55 for children 
from 2-13 years and adolescent girls and 0.70 for adolescent boys]
8). 
Spot urine microalbumin/creatinine ratio was expressed in SI units 
of mg/g and mg/mmol. Conversion to mg/mmol was calculated 
using the following formula: microalbumin/creatinine ratio (mg/
mmol)=urine microalbumin (mg/L)×1,000/urine creatinine (mg/
dL)×88.43. Statistical analysis was performed on log-transformed 
data, since the spot urine microalbumin/creatinine ratio approxi-
mates a log-normal distribution. Differences in mean values were 
evaluated by t-test and one-way ANOVA test. Comparisons 
between spot urine microalbumin/creatinine ratio and other vari-
ables were made using Pearson’s correlation analysis. A P-value of 
less than 0.05 was considered to be statistically significant.
Results
We studied 66 UTI patients (42 boys, 24 girls) and 52 normal 
children (24 boys, 28 girls). Ages were 19.1±26.8, 27.0±29.8 months 
respectively, ranging 1 month to 11 years old. In 28 children 
there was transient microscopic hematuria. Twenty one of UTI 
patients had VUR, 37 had renal parenchymal defects, 9 had renal 
scar. Anthropometric, laboratory and radiologic data are given in 
Table 1. The mean value of spot urine microalbumin (6.79±12.62 
mg/dL in patient group vs. 2.97±1.34 mg/dL in control group, 
P=0.0172), microalbumin/creatinine ratio in patient group showed 
a statistically significant increase compared to control group 
[340.04±321.36 mg/g (38.47±36.35 mg/mmol) in patient group 
vs. 225.68±154.61 mg/g (25.53±17.49 mg/mmol) in control group, 
Table 1. Clinial Characteristics Data of Groups
Patient (N=66) Control (N=52)
Age (months)
Sex (M/F)
Body weight (kg)
Weight z-score
Height (cm)
Height z-score
Body mass index (kg/m
2)
Body surface area (m
2)
Systolic blood pressure (mmHg)
Serum creatinine (mg/dL)
Hematuria (No.)
VUR (No.)
Renal parenchymal defect (No.)
Renal scar (No.)
Spot urine microalbumin (mg/dL)*
Spot urine creatinine (mg/dL)
Spot urine microalbumin/creatinine ratio 
[mg/g (mg/mmol)]*
Glomerular filtration rate (mL/min/1.73m
2)*
19.1±26.8
42/24
10.7±6.0
-0.09±0.97
76.9±20.6
-0.34±1.25
17.4±2.0
0.48±0.19
96.5±11.9
0.6±0.1
28
21
37
 9
6.79±12.62
17.66±17.90
340.04±321.36
(38.47±36.35)
61.90±16.67
27.0±29.8
24/28
12.4±5.6
-0.01±1.01
83.1±19.6
-0.59±1.23
17.6±2.4
0.53±0.18
101.3±12.2
0.6±0.1
0
0
0
0
2.97±1.34
19.82±15.83
225.68±154.61
(25.53±17.49)
69.35±16.45
Data are expressed as mean±SD
*P<0.05 for comparison between patient group and control group842      BO Kwak, et al. • Microalbuminuria in children with urinary tract infection
P=0.0141]. GFR in the patient group was statistically significantly 
decreased in comparison to the control group (61.90±16.67 mL/
min/1.72m
2 in patient group vs. 69.35±16.45 mL/min/1.72m
2 
in control group, P=0.0168) (Table 3). Age (r=-0.29, P=0.0167 in 
patient group, r=-0.41, P=0.0024 in control group), body surface 
area (BSA) (r=-0.29, P=0.0173 in patient group, r=-0.40, P=0.0030 
in control group), GFR (r=-0.26, P=0.0343 in patient group, r= 
-0.40, P=0.0030 in control group) were found to be negatively 
correlated to spot urine microalbumin/creatinine ratio (Table 2, Fig. 
1A, 1B). The mean value of spot urine microalbumin/creatinine 
ratio in 1-23 months age patient group showed a  statistically 
significant increase compared to control group (384.70±342.22 
mg/g (43.47±37.67 mg/mmol) in patient group vs. 264.92±158.13 
mg/g (29.94±17.86 mg/mmol) in control group, P=0.0341). GFR 
in 1-23 months age patient group showed a decrease compared to 
control group (56.87±12.85 mL/min/1.72m
2 in patient group vs 
61.33±11.04 mL/min/1.72m
2 in control group, P=0.1029), but it 
was no statistical significance (Table 3).  In a subset of 13 children 
with follow-up, mean spot urine microalbumin/creatinine ratio 
was statistically decreased (565.51±583.74 mg/g to 192.77±275.20 
mg/g, P=0.0481). Presence of transient microscopic hematuria 
(P=0.0169) was found to be correlated. VUR, VUR grade, renal 
parenchymal defect and renal scar were not correlated to spot urine 
microalbumin/creatinine ratio. 
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Fig. 1. (A) Correlation of age and microalbumin/creatinine ratio in the urinary tract infection (UTI) patient group. (B) 
Correlation of glomerular filtration rate (GFR) and microalbumin/creatinine ratio in the UTI group. 
Table 2. Correlation Analysis between Spot Urine Microalbumin/
Creatinine Ratio and Variables in Patient and Control Groups
Variables
Patient (N=66) Control (N=52)
r P-value r P-value
Age (months)*
Weight z-score
Height z-score
Body mass index (kg/m
2)
Body surface area (m
2)
Systolic blood pressure (mmHg)
Glomerular filtration rate (mL/min/1.73m
2)*
Serum creatinine (mg/dL)
-0.29
-0.02
-0.04
 0.10
-0.29
-0.13
-0.26
-0.18
0.0167
0.8643
0.7429
0.4295
0.0173
0.3264
0.0343
0.1476
-0.41
 0.23
 0.05
 0.24
-0.40
-0.12
-0.40
-0.21
0.0024
0.1052
0.7142
0.0827
0.0030
0.4343
0.0030
0.1466
*P<0.05 for comparison between patient group and control group
Table 3. Comparison between Patient and Control Groups according to the Age
Age Variables Patient Control P-value
<2 years
  (N=88)
Spot urine microalbumin (mg/dL)
Spot urine creatinine (mg/dL)
Spot urine microalbumin/creatinine ratio (mg/g (mg/mmol))*
Glomerular filtration rate (mL/min/1.73m
2) 
6.74±13.13
12.90±13.06
384.70±342.22 (43.47±37.67)
56.87±12.85
3.17±1.38
16.86±14.30
264.92±158.13 (29.94±17.86)
61.33±11.04
0.0572
0.1825
0.0341
0.1029
2-4 years 
  (N=11)
Spot urine microalbumin (mg/dL)
Spot urine creatinine (mg/dL)
Spot urine microalbumin/creatinine ratio (mg/g (mg/mmol))
Glomerular filtration rate (mL/min/1.73m
2)
7.25±6.00
35.80±22.95
198.97±121.03 (22.51±13.70)
82.17±16.49
2.56±0.92
17.00±9.94
185.06±86.10 (20.94±9.74)
83.60±6.05
0.1564
0.1011
0.8287
0.8623 
4-11 years 
  (N=19)
Spot urine microalbumin (mg/dL)
Spot urine creatinine (mg/dL)
Spot urine microalbumin/creatinine ratio (mg/g (mg/mmol))
Glomerular filtration rate (mL/min/1.73m
2)
6.88±13.24
35.11±23.62
170.30±176.88 (19.26±20.01)
82.15±12.94
2.53±1.33
32.20±18.94
116.61±119.19 (13.19±13.48)
90.86±11.22
0.3550
0.7694
0.4441
0.1346
*P<0.05 for comparison between patient group and control groupKorean J Pediatr 2010;53(9):840-844 • DOI: 10.3345/kjp.2010.53.9.844    843
Discussion
Although UTI is a common disease in children and is said to be 
associated with proteinuria or microalbuminuria, the relationship 
between microalbuminuria and UTI remains incompletely 
defined
11). Brocklebank et al.
12) demonstrated a mixed tubular/
glomerular pattern of proteinuria in patients with ureteral reflux. 
There exist studies that utilized specific quantitative immunoassays 
to demonstrate tubular proteinuria patterns in patients with 
pyelonephritis
13). It was well known that epithelial cells lining 
the proximal tubule reabsorbed filtered albumin using receptor-
mediated endocytosis. Microalbuminuria results when the filtered 
load of albumin exceeds tubular re-absorptive capacity
14, 15). In 
glomerular injury, the filter became more ‘leaky’ and allowed 
greater amounts to filter through, overwhelming the tubular re-
absorption mechanism in the meantime
16). It was thought that 
patients with severe pyelonephritis or renal scar could have had 
compensatory hyperfiltration in the remaining nephrons and 
developed progressive glomerulosclerosis, as evidenced by increased 
urine microalbumin excretion
13, 17). A recent report suggested that 
microalbuminuria might promote tubular injury with interstitial 
inflammation and eventual fibrosis
18). Khatib et al.
19) found focal 
segmental glomerulosclerosis in adult patients with renal scarring, 
and good correlation was observed between the presence and extent 
of focal glomerulosclerosis, and the degree of proteinuria. Therefore 
it could be said that early microalbuminuria in patients with 
UTI is an indicator of high permeability of glomerular basement 
membrane (GBM) and disease progression.
Few study investigated spot urine microalbumin/creatinine 
ratio in children
5, 6). Several prior reports indicated that spot urine 
samples provide a good estimate of the 24-hour excretion rate
20, 
21). However, 24-hour timed urine collection is hard to obtain in 
pediatric patients, whereas spot urine microalbumin/creatinine 
ratio represents a simple and reliable clinical marker for early 
identification of renal injury in children with UTI
22, 23).
In this study, the level of microalbumin and the spot urine 
microalbumin/creatinine ratio were higher in the patient group 
compared to control, and the absolute number of children with 
microalbuminuria was large (N=112). Spot urine microalbumin/
creatinine ratio is simple to obtain, but the result may incorrectly 
suggest elevated microalbumin excretion rate simply because the 
patient has low creatinine excretion due to reduced muscle mass, 
particularly in women and infants
15, 24). Most children included 
in this study were less than 2 years-old, therefore the spot urine 
creatinine and microalbumin/creatinine ratio of children might 
be increased compared to that of adults. Because the children 
included in this study were younger than other reported studies, 
the prevalence of microalbuminuria is high. It was observed that 
mean spot urine microalbumin/creatinine ratio for 1-23 months 
was 384.70±342.22 mg/g (43.47±37.67 mmol/mg) dropping to 
170.30±176.88 mg/g (19.26±20.01 mmol/mg) for 4-11 years age 
group. It could be due to a decreased in the amount of filtered 
albumin or to an increased in tubular reabsorption and catabolism 
following maturation of the proximal tubules with age
25). In a subset 
of 13 children with follow-up, the value was statistically decreased. 
Kim et al.
26) reported elevated albuminuria is largely transient in 
nondiabetic youth, but persistent and progressive in those with 
diabetes. In this study, as most of the patient group had short disease 
duration and no permanent renal disease, microalbuminuria in 
UTI patient group is transient. With further study, it might be used 
as an early detector and a follow-up marker in UTI patients.
In patient and control groups, BSA and GFR were negatively 
correlated to spot urine microalbumin creatinine ratio. Karlen et 
al.
13) reported GFR was negatively correlated to urine microalbumin 
excretion in patients with pyelonephritic renal injuries, and Keijzer-
Veen et al.
27) reported 19-year-old subjects born very premature 
or intrauterine growth retardation (IUGR) had low GFR and 
microalbuminuria. Birth weight was associated negatively with 
microalbumin/creatinine ratio and positively with GFR. 
A limitation of this study is that only one spot urine micro-
albumin/creatinine ratio was obtained, and it was not compared 
to timed urine collections. Yoon et al.
5) reported that the spot 
urine microalbumin/creatinine ratio was significantly increased 
in children with VUR and renal defects. Basic et al.
18) determined 
the presence of microalbuminuria and decreased creatinine 
clearancerate (CCR) in children with high grade of VUR. In this 
study VUR, VUR grade, renal parenchymal defect and renal scar 
were not correlated to microalbuminuria. The discrepancy between 
the findings reported in our study and reported by Yoon et al.
5) is 
likely due to difference of mean age of patients, severity of disease. 
Therefore further longitudinal follow-ups are required to confirm 
the apparent absence of correlation.
In conclusion, the spot urine microalbumin/creatinine ratio 
in children with UTI was statistically significantly increased 
compared to that of normal children. In addition, the spot urine 
microalbumin/creatinine ratio was related to GFR. The ratio could 
potentially be used as a pre-screening and prognostic marker in UTI 
patients. Further studies are required to validate the predictability of 
microalbuminuria in pediatric UTI patients.844      BO Kwak, et al. • Microalbuminuria in children with urinary tract infection
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